Abstract
The increase in the consumption of psychotherapeutic drugs, and particularly of sedatives and hypnotics, has led to increasing concern about the overprescribing and abuse of these drugs by the public. The study of drug consumption, and eventually the identification of particular areas of misuse, soon leads to a search for medical, social or cultural factors which can influence drug utilization. Drug utilization has been defined by the World Health Organization (1977) as ‘the marketing, distribution, prescription and use of drugs in a society, with special emphasis on the resulting medical, social and economic consequences’. Five questions arise when the utilization of sedatives and hypnotics is to be studied: (1) which are the characteristics of the milieu which may have some influence on the consumption of these drugs; (2) which are the characteristics of the supply of these drugs; (3) which are the most consumed drugs; (4) how are these drugs prescribed, dispensed and consumed; and (5) which (if any) are the effects of the consumption of these drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baksaas, I. and Lunde, P.K.M. (1981). Drug utilization: pharmacokinetics in the community. Trends in Pharmacol. Sci., 2(2), V–VII.
Balter, M.B., Levine, J. and Manheimer, D.I. (1974). Cross-national study of the extent of anti-anxiety/sedative drug use. New Engl. J. Med., 290, 769–74.
Bellantuono, C., Reggi, V., Tognoni, G. and Garattini, S. (1980). Benzodiazepines: clinical pharmacology and therapeutic use. Drugs, 19, 195–219.
Bergman, U., Agenäs, I. and Dahlström, M. (1983). Utilization of psychotropic drugs in Sweden and the other Nordic countries. This volume, pp. 3–17.
Berman, L.B., Jeghers, H., Schreiner, G.E. and Pallotta, A.J. (1956). Hemodialysis, an effective therapy for acute barbiturate poisoning. J. Am. Med. Assoc., 161, 820–7.
Camí, J., Frati, M.E. and Martín, M.L. (1980). Intoxicación aguda en Barcelona. Epidemiología y consideraciones sobre su terapéutica. Med. Clin. (Barcelona), 75, 287–91.
Consejo General de Colegios Oficiales de Farmacéuticos (1981). Catálogo de Especialidades Farmacéuticas 1981, CGCOF, Madrid.
Department of International Economic and Social Affairs Statistical Office (1979). Statistical Yearbook 1978, United Nations, New York.
Erill, S. (1974). Clinical pharmacology in Spain. Clin. Pharmacol. Ther., 16, 597–604.
Erill, S., García Sevilla, J.A. and Laporte, J.R. (1973). Las especialidades farmacéuticas en España: un análisis del Vademecum Daimon 1971. Anales de Medicina, 54, 215–20.
Frati, M.E. (1982). Intervención farmacológico-clínica en el tratamiento de las intoxicaciones agudas en la UCI. Tesis doctoral, Universitat Autònoma de Barcelona, Barcelona.
Gabinet d’Assessoria i Promoció de la Salut (1979). L’Assistència Externa de la Seguretat Social a Barcelona, Col.legi Oficial de Metges, Barcelona.
Gisbert, R. (1981). La demanda y el consumo de medicamentos en España durante el período 1970–1979. In Primeres Jornades Sobre Economia de la Salut, Col.legi d’Economistes de Catalunya, Barcelona, pp. 65–79.
Grimsson, A., Idänpään-Heikkilä, J., Lunde, P.K.M., Olafsson, O. and Westerholm, B. (1979). The utilization of psychotropic drugs in Finland, Iceland, Norway and Sweden. In Studies in Drug Utilization (eds U. Bergman, A. Grimsson, A.H.W. Wahba and B. Westerholm), WHO Regional Office for Europe, Copenhagen, pp. 163–73.
Harvey, S.C. (1980). Hypnotics and sedatives. In The Pharmacological Basis of Therapeutics, 6th edn (eds A. Goodman Gilman, L.S. Goodman and A. Gilman), Macmillan, New York, p. 359.
Hemminki, E. (1981). Sales of Psychotropic Drugs in Finland, Norway, and Sweden in the 1960s and 1970s: Descriptive Material, Publications of the University of Kuopio, Kuopio.
King, D.J., Griffiths, K., Hall, C.E., Cooper, N.C. and Morrison, D.J. (1980). Effect of the CURB campaign on barbiturate prescribing in Northern Ireland. J. R. Coll. Gen. Pract., 30, 614–8.
Laporte, J. (1975). El abuso de medicamentos. In Avances en Terapéutica, vol. 6 (eds J. Laporte and J.A. Salvà), Salvat, Barcelona, pp. 1–25.
Laporte, J.R. (1981). Drug consumption in Spain. Lancet, i, 103–4.
Laporte, J.R., Capellà, D., Gisbert, R., Porta, M., Frati, M.E., García Santesmases, M.P. and García Iñesta, A. (1981). The utilization of sedative-hypnotic drugs in Spain. In Epidemiological Impact of Psychotropic Drugs (eds G. Tognoni, C. Bellantuono and M. Lader), Elsevier/North-Holland, Amsterdam, pp. 137–49.
Baksaas, I. and Lunde, P.K.M. (1981). Drug utilization: pharmacokinetics in the community. Trends in Pharmacol. Sci., 2(2), V–VII.
Balter, M.B., Levine, J. and Manheimer, D.I. (1974). Cross-national study of the extent of anti-anxiety/sedative drug use. New Engl. J. Med., 290, 769–74.
Bellantuono, C., Reggi, V., Tognoni, G. and Garattini, S. (1980). Benzodiazepines: clinical pharmacology and therapeutic use. Drugs, 19, 195–219.
Bergman, U., Agenäs, I. and Dahlström, M. (1983). Utilization of psychotropic drugs in Sweden and the other Nordic countries. This volume, pp. 3–17.
Berman, L.B., Jeghers, H., Schreiner, G.E. and Pallotta, A.J. (1956). Hemodialysis, an effective therapy for acute barbiturate poisoning. J. Am. Med. Assoc., 161, 820–7.
Camí, J., Frati, M.E. and Martín, M.L. (1980). Intoxicación aguda en Barcelona. Epidemiología y consideraciones sobre su terapéutica. Med. Clin. (Barcelona), 75, 287–91.
Consejo General de Colegios Oficiales de Farmacéuticos (1981). Catálogo de Especialidades Farmacéuticas 1981, CGCOF, Madrid.
Department of International Economic and Social Affairs Statistical Office (1979). Statistical Yearbook 1978, United Nations, New York.
Erill, S. (1974). Clinical pharmacology in Spain. Clin. Pharmacol. Ther., 16, 597–604.
Erill, S., García Sevilla, J.A. and Laporte, J.R. (1973). Las especialidades farmacéuticas en España: un análisis del Vademecum Daimon 1971. Anales de Medicina, 54, 215–20.
Frati, M.E. (1982). Intervención farmacológico-clínica en el tratamiento de las intoxicaciones agudas en la UCI. Tesis doctoral, Universitat Autònoma de Barcelona, Barcelona.
Gabinet d’Assessoria i Promoció de la Salut (1979). L’Assistència Externa de la Seguretat Social a Barcelona, Col.legi Oficial de Metges, Barcelona.
Gisbert, R. (1981). La demanda y el consumo de medicamentos en España durante el período 1970–1979. In Primeres Jornades Sobre Economia de la Salut, Col.legi d’Economistes de Catalunya, Barcelona, pp. 65–79.
Grimsson, A., Idänpään-Heikkilä, J., Lunde, P.K.M., Olafsson, O. and Westerholm, B. (1979). The utilization of psychotropic drugs in Finland, Iceland, Norway and Sweden. In Studies in Drug Utilization (eds U. Bergman, A. Grimsson, A.H.W. Wahba and B. Westerholm), WHO Regional Office for Europe, Copenhagen, pp. 163–73.
Harvey, S.C. (1980). Hypnotics and sedatives. In The Pharmacological Basis of Therapeutics, 6th edn (eds A. Goodman Gilman, L.S. Goodman and A. Gilman), Macmillan, New York, p. 359.
Hemminki, E. (1981). Sales of Psychotropic Drugs in Finland, Norway, and Sweden in the 1960s and 1970s: Descriptive Material, Publications of the University of Kuopio, Kuopio.
King, D.J., Griffiths, K., Hall, C.E., Cooper, N.C. and Morrison, D.J. (1980). Effect of the CURB campaign on barbiturate prescribing in Northern Ireland. J. R. Coll. Gen. Pract., 30, 614–8.
Laporte, J. (1975). El abuso de medicamentos. In Avances en Terapéutica, vol. 6 (eds J. Laporte and J.A. Salvà), Salvat, Barcelona, pp. 1–25.
Laporte, J.R. (1981). Drug consumption in Spain. Lancet, i, 103–4.
Laporte, J.R., Capellà, D., Gisbert, R., Porta, M., Frati, M.E., García Santesmases, M.P. and García Iñesta, A. (1981). The utilization of sedative-hypnotic drugs in Spain. In Epidemiological Impact of Psychotropic Drugs (eds G. Tognoni, C. Bellantuono and M. Lader), Elsevier/North-Holland, Amsterdam, pp. 137–49.
Lunde, P.K.M. (1980a). The World Health Organization essential drug concept — three years afterwards. In Clinical Pharmacology and Therapeutics: Proc. of Plenary Lectures, Symposia and Therapeutic Sessions of the First World Conf. on Clinical Pharmacology and Therapeutics (ed P. Turner), Macmillan, London, pp. 529–35.
Lunde, P.K.M. (1980b). Drug and product selection — an essential part of the therapeutic benefit/risk ratio strategy? In Drug-Induced Sufferings: Proc. of the Kyoto Int. Conf. Against Drug-Induced Sufferings (ed T. Soda), Elsevier/North-Holland, Amsterdam, pp. 129–36.
Lunde, P.K.M., Baksaas, I., Halse, M., Halvorsen, I.K., Strømmes, B. and Øydvin, K. (1979). The methodology of drug utilization studies. In Studies in Drug Utilization (eds U. Bergman, A. Grimsson, A.H.W. Wahba and B. Westerholm), WHO Regional Office for Europe, Copenhagen, pp. 17–28.
Martin, M.L., Busquet, L., Arnau, J.M., Arboix, M., Frati, M.E. and Casas, M. (1980). Medicines at home and attitudes of public towards medicines. In World Conf. on Clinical Pharmacology and Therapeutics (eds P. Turner and C. Padgham), Macmillan, London, Abstracts, no. 0749.
Mas, X., Laporte, J.R., Frati, M.E., Busquet, L., Arnau, J.M., Ibañez, L., Séculi, E., Capellà, D. and Arbonés, G. (in press). Drug prescribing and drug use among elderly people in Spain. Drug. Intell. Clin. Pharm.
Mas, X., Laporte, J.R. and Martin, M.L. (1981). Drugs and the elderly. Br. Med. J., 282, 824.
Ministerio de la Gobernación (1970). Decreto 849/1970 de 21 de marzo, por el que se actualizan algunas disposiciones vigentes en materia de registro, comercialización y publicidad de especialidades farmacéuticas. Boletín Oficial del Estado, 310–82, 5370–1.
Ministerio de Trabajo, Sanidad y Seguridad Social (1981). Real Decreto 2730/1981 de 19 de octubre, sobre registro de especialidades farmacéuticas publicitarias. Boletín Oficial del Estado de 25 de noviembre de 1981.
Nordic Council on Medicines (1979). Nordic Statistics on Medicines 1975–1977, part 1, Statistical Reports of the Nordic Countries, 35, Nordic Council on Medicines, Helsinki.
Poklis, A. and Gantner, G.E. (1981). Drug deaths in St. Louis City and County: a brief survey, 1977–1979. Clin. Toxicol., 18, 141–7.
Stika, L. and Vinař, O. (1980). Utilization of psychotropic drugs. An international comparison. Activ. Nerv. Sup. (Praha), 22, 221–4.
World Health Organization Expert Committee (1977). The Selection of Essential Drugs, WHO Technical Report Series, 615, WHO, Geneva.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1983 The contributors
About this chapter
Cite this chapter
Laporte, JR., Capellà, D., Porta, M., Frati, M.E. (1983). Patterns of use of psychotropic drugs in Spain in an international perspective. In: Gram, L.F., Usdin, E., Dahl, S.G., Kragh-Sørensen, P., Sjöqvist, F., Morselli, P.L. (eds) Clinical Pharmacology in Psychiatry. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06671-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-349-06671-1_2
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-06673-5
Online ISBN: 978-1-349-06671-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)